Literature DB >> 13182626

Acne conglobata; use of cortisone and corticotropin in therapy.

E M FARBER, E R CLAIBORNE.   

Abstract

Six patients with acne conglobata were treated with cortisone and adrenocorticotropic hormone. Definite immediate improvement was observed in all of them. In three cases control of the disease was maintained on relatively low doses of steroid. In one case there was response to superficial x-ray therapy after the acute phase of the disease had subsided in response to steroids. Resistance to steroid therapy apparently developed in one patient after approximately 18 months of treatment. One patient responded to treatment and then remained well (for two months when last observed) although steroids and all other treatment were discontinued. The combined use of antibiotics and steroids in the patients treated gave the best results.

Entities:  

Keywords:  ACNE; ACTH/therapeutic use; CORTISONE/therapeutic use

Mesh:

Substances:

Year:  1954        PMID: 13182626      PMCID: PMC1532266     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  3 in total

1.  Cortisone.

Authors:  J M CARLISLE; A GIBSON; E SCHMATOLLA
Journal:  Postgrad Med       Date:  1950-08       Impact factor: 3.840

2.  Observations on the physiologic effects of cortisone and ACTH in man.

Authors:  R G SPRAGUE; M H POWER
Journal:  Arch Intern Med (Chic)       Date:  1950-02

3.  The mechanism of action of 17-hydroxy-11-dehydrocorticosterone (compound E) and of the adrenocorticotropic hormone in experimental hypersensitivity in rabbits.

Authors:  F G GERMUTH; J OYAMA; B OTTINGER
Journal:  J Exp Med       Date:  1951-08       Impact factor: 14.307

  3 in total
  2 in total

1.  Acne conglobata and arthritis: report of a case and review of the literature.

Authors:  M Ehrenfeld; Y Samra; N Kaplinsky
Journal:  Clin Rheumatol       Date:  1986-09       Impact factor: 2.980

2.  Induction of acne by topical steroids.

Authors:  G Plewig; A M Kligman
Journal:  Arch Dermatol Forsch       Date:  1973
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.